Skip to content

High Resolution Retinal Imaging

High Resolution Retinal Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01866371
Acronym
AOSLO
Enrollment
600
Registered
2013-05-31
Start date
2013-05-31
Completion date
2027-12-31
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stargardts, Retinitis Pigmentosa, Age-related Macular Degeneration, Choroideremia, Geographic Atrophy

Keywords

Retina, imaging, retinal degeneration

Brief summary

Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics scanning laser ophthalmoscope (AOSLO) to image the normal and diseased retina with individual cellular resolution non-invasively. The primary objective of this study is to obtain and analyze high-resolution images of the retina, in particular by imaging the cone photoreceptor mosaic, the retinal vasculature and other retinal layers. The study design will involve case-control studies, where cases are followed over time. Subjects age 7 and older may be invited to participate. The main research procedure involves retinal imaging with the AOSLO. The primary endpoint is the observation of differences in retinal images between subjects with and without retinal diseases. These changes will be quantified by examining the cell density, size, spacing and regularity of the cone photoreceptor mosaic, as well as examining the differences between other retinal layers.

Interventions

Retinal imaging procedures include adaptive optics imaging, optical coherence tomography and fundus photography.

Sponsors

National Eye Institute (NEI)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males or females age 7 years or older. * Parental/guardian permission (informed consent) and if appropriate, child assent. Child subjects age 7-17 must give assent. * Reasonable compliance with an imaging protocol as determined by the study personnel.

Exclusion criteria

* Individuals that are at risk to acute glaucoma. * Individuals that are photophobic and experience adverse psychological reactions to flashes of light. * Ocular opacities, high refractive error, and high frequency of nystagmus as determined by the study team.

Design outcomes

Primary

MeasureTime frameDescription
high-resolution images of retina1 day (initial visit)The primary objective of this study is to obtain and analyze high-resolution images of the retina in normal and diseased eyes non-invasively.

Secondary

MeasureTime frameDescription
Cone mosaic parameters1 day (initial visit)Imaging the cone photoreceptor mosaic, and analyzing cell density, size, spacing, regularity, and other mosaic parameters in normal retina compared to diseased retina.

Countries

United States

Contacts

Primary ContactJessica IW Morgan, PhD
jwmorgan@pennmedicine.upenn.edu215-614-4196

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026